For the Inventor, By the Inventor

Enter assignee name

Biocure Limited

USPTO Granted Patents = 15

% Expired Patents = 26.7

EPO Patents = 2

Trademarks = 3

Forward Citations = 636

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Hassan Chaouk (8 out of 24 patents)

Bruktawit T Asfaw (8 out of 11 patents)

Troy Vernon Holland (7 out of 50 patents)

4. Dennis W Goupil (6 out of 7 patents)

5. Stephen D Goodrich (6 out of 14 patents)

6. Lucas Latini (6 out of 7 patents)

7. Thomas Hirt (3 out of 12 patents)

8. Wolfgang Meier (3 out of 6 patents)

9. Corinne Nardin (2 out of 2 patents)

10. Eileen T Grant (2 out of 2 patents)

11. Graham T Bell (2 out of 2 patents)

12. Stephen Bloor (2 out of 2 patents)

13. Claude-Raymond René (1 out of 3 patents)

14. John C Jackson (1 out of 1 patent)

15. Zhihua Lu (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. RE48302 - Embolic compositions (2020-11-09),

2. RE47121 - Embolic compositions (2018-11-12),

3. 9232805 - In-situ forming hydrogel wound dressings containing antimicrobial agents (2016-01-12),

4. 8221735 - Embolic compositions (2012-07-17),

5. 7666339 - Hydrogel string medical device (2010-02-23),

6. 7070809 - Hydrogel biomedical articles (2006-07-04),

7. 6916488 - Amphiphilic polymeric vesicles (2005-07-12),

8. 6723814 - Amphiphilic copolymer planar membranes (2004-04-20),

9. 6710126 - Degradable poly(vinyl alcohol) hydrogels (2004-03-23),

10. 6676971 - Embolic compositions (2004-01-13),

11. 6652883 - Tissue bulking and coating compositions (2003-11-25),

12. 6616946 - Triblock copolymer hollow particles for agent delivery by permeability change (2003-09-09),

13. 6475790 - Assay for screening agents that alter angiogenesis (2002-11-05),

14. 6225118 - Multicellular in vitro assay of angiogenesis (2001-05-01),

15. 5684166 - (-3-ketotetrahydrofuran-2-yl) ethanal derivatives and a method for their (1997-11-04),

Biocure Limited is a UK-based biotechnology company focused on developing innovative therapeutic solutions for various medical conditions. The organization specializes in advanced drug delivery systems and regenerative medicine, leveraging cutting-edge research to enhance patient outcomes. With a commitment to scientific excellence, Biocure aims to address unmet medical needs through its proprietary technologies and collaborative partnerships, positioning itself as a key player in the evolving landscape of healthcare solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

15 Patents

#68 in

#1,180 in United Kingdom

#39,846 in the World

Biocure Limited

Forward Citations = 636

22 inventors:

Hassan Chaouk (8 out of 24 patents)

Bruktawit T Asfaw (8 out of 11 patents)

Troy Vernon Holland (7 out of 50 patents)

4. Dennis W Goupil (6 out of 7 patents)

5. Stephen D Goodrich (6 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…